GlassScriptPhysician profile
Anne Banfield
NPI 1992931703
$613.78
in general payments reported to CMS, 2019-2025
11 companies · $59.52 in 2025
The $59.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $58.53 · 2021: $59.11 · 2022: $75.81 · 2023: $43.59 · 2024: $63.81 · 2025: $59.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $135.24 | 2019-2021 | |
| Abbvie INC. | $117.73 | 2019-2020 | |
| Organon LLC | $96.17 | 2023-2025 | Nexplanon |
| Ethicon US, LLC | $55.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.76 | 2022-2023 | |
| Pfizer INC. | $37.45 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $33.35 | 2025 | |
| Becton, Dickinson and Company | $28.00 | 2022 | |
| Hologic Sales and Service, LLC | $23.36 | 2021 | |
| Minerva Surgical, INC | $22.81 | 2019 | |
| Therapeuticsmd, INC. | $16.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Banfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.